Boston Professional Events List


13TH ANNUAL CMHC


Date
Oct 24, 2018 - 08:00 AM
Organizer
CMHC
Location
Boston Sheraton Hotel39 Dalton St.,

Boston, ,
MA,
US,
ZIP: 02199
Phone:

13TH ANNUAL CMHC

Wednesday, October 24, 2018

More than one-third of the population has at least one cardiometabolic risk factor - dyslipidemia, CVD, hypertension, diabetes, and/or obesity. Now in its 13th year, the Cardiometabolic Health Congress is the largest, US-based, multidisciplinary conference focused solely on the management of cardiometabolic risk and the prevention of cardiovascular and metabolic disease. The 3 ½- day event offers today's busy healthcare professionals a one-of-a-kind opportunity to learn real-world solutions they can integrate immediately into their clinical practices.

Session topics include:

Risk Factors for Dyslipidemia, Atherosclerosis, and Cardiovascular Disease
The Effect of Circadian Rhythm on Obesity and CVD
Diet Quality, Quantity, and Beyond in Cardiometabolic Disorders
Insulin and Non-Insulin Therapies for Diabetes Management
Challenging Patient Cases in Hypertension, Cardio-renal, and Heart Failure
EARN 21+
CME CREDIT HOURS

WOMEN'S HEALTH SUMMIT: CARDIOMETABOLIC HEALTH ACROSS THE LIFESPAN
10:30 - 10:40 am

Introduction to CMHC Women's Health Summit

Pamela B. Morris, MD

10:40 - 11:10 am

Cardio-oncology: An emerging field

Ana Barac, MD

11:10 - 11:40 am

The Intersection Between Breast Cancer and Cardiovascular Disease

Ana Barac, MD

11:40 - 11:55 am

Interactive Participant Q&A Session

Ana Barac, MD

12:00 - 1:00 pm

PME Lunch Symposium (Non-CME)
Sponsored by Amgen, Inc.

1:10 - 1:15 pm

Welcome Back to Women’s Health Summit

Pamela B. Morris, MD

1:15 - 1:45 pm

Cardiometabolic Risk in PCOS and Implications for Management

Andrea E. Dunaif, MD

1:45 - 2:15 pm

Impact of Pregnancy on CV Risk Factors and ASCVD Risk

Pam R. Taub, MD

2:15 - 2:30 pm

Nutrition Break

2:30 - 3:00 pm

Choosing Wisely: Contraception in Women with Cardiometabolic Risk

Nieca Goldberg, MD

3:00 - 3:30 pm

Updates on the Role of Postmenopausal Hormone Replacement Therapy

JoAnn E. Manson, MD, DrPH, FAHA

3:30 - 3:50 pm

Women’s Health Summit Expert Panel Discussion and Q&A

Chair:Pamela B. Morris, MD

Panelists: Andrea E. Dunaif, MD
‌Pam R. Taub, MD
‌JoAnn E. Manson, MD, DrPH, FAHA

3:50 - 4:00 pm

Conclusions to CMHC Women’s Health Summit

Pamela B. Morris, MD

4:15 - 5:15 pm

PME Light Bites Session (Non-CME)
Sponsored by the American Society for Preventive Cardiology

5:30 - 6:30 pm

PME Light Bites Session (Non-CME)

Serge Jabbour, MD
Sponsored by Janssen Pharmaceuticals, Inc.

6:45 - 7:45 pm

PME Dinner Symposium (Non-CME)
Sponsored by Amarin Pharma, Inc.

Thursday, October 25, 2018 CMHC GENERAL SESSIONS
Session I: Diabetes Management

6:30 - 7:45 am

CME Breakfast Symposium

The Role of CGM in Individualization of T2DM Management

Chair: Anne L. Peters, MD

Presenter: Irl B. Hirsch, MD

Supported in part by an educational grant from Dexcom, Inc..

7:55 - 8:00 am

Opening Remarks

Jay S. Skyler, MD

8:00 - 9:30 am

FDA Update and Late Breaking Clinical Trials

Chair:Christie M. Ballantyne, MD

Panelists:Robert H. Eckel, MD
‌Jay S. Skyler, MD
‌Keith C. Ferdinand, MD
‌Deepak L. Bhatt, MD, MPH

9:30 - 10:15 am

KEYNOTE

C. Ronald Kahn, MD

10:15 - 11:15 am

Morning Break - Exhibit Hall

11:15 am - 12:00 pm

So Many Options - Dispelling the Confusion About Insulins

Irl B. Hirsch, MD

12:10 - 1:25 pm

CME Lunch Symposium A
Management of T2DM Patients with Diabetic Kidney Disease: Effects of SGLT2 Inhibitors and GLP1 Receptor Agonists on Disease Progression

Chair: Matt Weir, MD

Presenters: Lance Sloan, MD; Robert D. Toto, MD

Supported by educational grants from Janssen Pharmaceuticals, Inc., administered by Janssen Scientific Affairs, LLC. and by Boehringer Ingelheim Pharmaceuticals, Inc. and Lilly USA, LLC

12:10 - 1:25 pm

CME Lunch Symposium B
Advances in HFpEF: Addressing Diagnostic and Treatment Challenges

Chair: JoAnn Lindenfeld, MD

Presenters: Keith C. Ferdinand, MD; Alanna A. Morris, MD

Supported by an educational grant from Novartis Pharmaceuticals Corporation.

1:35 - 2:20 pm

Where Are We with Devices for Diabetes Management?

Anne L. Peters, MD

2:20 - 3:20 pm

Afternoon Break - Exhibit Hall

3:20 - 3:50 pm

How Many GLP1 RAs Do We Need and Why?

John B. Buse, MD

3:50 - 5:05 pm

Multidisciplinary Case Consults

Chair:Jay S. Skyler, MD

Panelists: John B. Buse, MD
‌Robert H. Eckel, MD
‌Davida F. Kruger, MSN, APNBC, BCADM
‌Anne L. Peters, MD
‌Irl B. Hirsch, MD

5:10 - 6:10 pm

Welcome Reception - Exhibit Hall

6:20 - 7:35 pm

CME Dinner Symposium

Mastering the Prior Authorization Process to Meet Patient Needs

Chair: Pamela B. Morris, MD

Presenters: Christie M. Ballantyne, MD; Kim K. Birtcher, PharmD

Supported by an educational grant from Sanofi US and Regeneron Pharmaceuticals.

7:40 - 8:40 pm

PME Dinner Symposium (Non-CME)

Sponsored by Akcea Therapeutics

Friday, October 26, 2018 CMHC GENERAL SESSIONS
Session II: Obesity and Lifestyle Management in Cardiovascular Disease

6:30 - 7:45 am

CME Breakfast Symposium

The ABC Access Program: Overcoming Barriers to Access of Newer Cardiovascular Agents for High-Risk and Minority Patients

Chair: Keith C. Ferdinand, MD

Faculty: Deirdre Mattina, MD; Catherine Davis Ahmed, MBA

Supported by an educational funding donation provided by Amgen and in partnership with the Association of Black Cardiologists, Inc (ABC).

7:55 - 8:00 am

Opening Remarks
Robert H. Eckel, MD

8:00 - 8:45 am

Heart Healthy Nutrition

Stephen Devries, MD

8:45 - 9:15 am

Updates on the Microbiome and Metabolic Surgery

Mary-Elizabeth Patti, MD

9:15 - 10:15 am

Morning Break - Exhibit Hall

10:15 - 11:00 am

Obesity and Environmental Influence: The Big Picture

James O. Hill, PhD

11:00 - 11:45 am

Day to Day Management of Obesity in Clinical Practice

Robert F. Kushner, MD

11:45 - 11:50 am

Closing Remarks
Robert H. Eckel, MD

12:00 - 1:15 pm

CME Lunch Symposium
Identifying, Diagnosing and Managing Iron Deficiency in Patients with Heart Failure to Improve Outcomes and Quality of Life

Presenters: Biykem Bozkurt, MD; Gurushner Panjrath, MD

Supported by an educational grant from American Regent.

Session III: Dyslipidemia, Atherosclerosis, and Cardiovascular Disease Risk Reduction

1:25 - 1:30 pm

Opening Remarks
Christie M. Ballantyne, MD

1:30 - 2:20 pm

Targeting Inflammation: Updates on Pathophysiology and Clinical Outcomes

Peter Libby, MD;
Paul M. Ridker, MD

This session is supported by an educational grant from Novartis Pharmaceuticals Corporation.

2:20 - 3:20 pm

Afternoon Break - Exhibit Hall

3:20 - 4:10 pm

How Aggressively Do We Lower LDL-C and for Which Patients?

Vera A. Bittner, MD, MSPH;
Marc S. Sabatine, MD, MPH

4:10 - 5:00 pm

Risk Assessment for Global Cardiovascular Disease: Imaging and Biomarkers

Matthew J. Budoff, MD;
James de Lemos, MD

5:00 - 6:00 pm

Multidisciplinary Case Consults

Chair:Christie M. Ballantyne, MD

Panelists: Robert H. Eckel, MD
‌Pamela B. Morris, MD
‌Margo B. Minissian, PhD, ACNP
‌Pam R. Taub, MD
‌Vera A. Bittner, MD, MSPH

This session is supported by educational grants from Amarin Pharma, Inc and Akcea Therapeutics.

6:00 - 6:05 pm

Closing Remarks
Christie M. Ballantyne, MD

6:05 - 7:05 pm

Closing Reception - Exhibit Hall

7:15 - 8:15 pm

PME Dinner Symposium (Non-CME)

Sponsored by Novo Nordisk

Saturday, October 27, 2018 CMHC GENERAL SESSIONS
Session IV: Hypertension, Cardio-renal, and Heart Failure

6:30 - 7:45 am

CME Breakfast Symposium

7:55 - 8:00 am

Opening Remarks
George L. Bakris, MD

8:00 - 9:00 am

Overview of the New 2017 Hypertension Clinical Practice Guidelines

George L. Bakris, MD

9:00 - 9:30 am

Comparing the Hypertension Guidelines - Where is the Equipoise?

William B. White, MD

9:30 - 9:45 am

Nutrition Break

9:45 - 10:45 am

Patient Cases: How would you change the management of hypertension based on the new guidelines?

Aldo Peixoto, MD; William B. White, MD; Keith C. Ferdinand, MD

10:45 - 11:15 am

Prevention of Heart Failure: The Next Frontier

Clyde W. Yancy, MD

11:15 - 11:25 am

Mini Break

11:25 - 11:55 am

Integration of Biomarkers and Prediction of AKI and Cardio-renal Outcomes in Clinical Practice

Aldo Peixoto, MD

11:55 am - 12:25 pm

AKI and Heart Failure: How to manage compared to general population?

Peter A. McCullough, MD

12:25 - 12:55 pm

Advanced CKD and Benefits From CVOTs

Jorge Plutzky, MD

12:55 - 1:00 pm

Closing Remarks

JOA180514CEV

Event Categories




Comments








Events Calendar

SunMonTueWedThuFriSat
30 1 2 3 4 5 6
7 8 9 10 11 12 13
14 15 16 17 18 19 20
21 22 23 24 25 26 27
28 29 30 31 1 2 3

Newsletters

Subscribe
VIP Life Time Subscription to our Newsletters!
$399.99
$299.99